BNTX
BioNTech SENASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$21.79B
P/E Ratio
—
EPS
$-5.84
Beta
1.32
52W High
$124.00
52W Low
$79.52
50-Day MA
$94.79
200-Day MA
$100.04
Dividend Yield
—
Profit Margin
-44.60%
Forward P/E
7.04
PEG Ratio
0.05
About BioNTech SE
BioNTech SE, a biotechnology company, develops and markets immunotherapies for cancer and other infectious diseases. The company is headquartered in Mainz, Germany.
Fundamentals
| Revenue (TTM) | $2.81B |
| Gross Profit (TTM) | $2.21B |
| EBITDA | $-1.19B |
| Operating Margin | -577.00% |
| Return on Equity | -6.66% |
| Return on Assets | -4.18% |
| Revenue/Share (TTM) | $11.45 |
| Book Value | $85.19 |
| Price-to-Book | 1.03 |
| Price-to-Sales (TTM) | 7.77 |
| EV/Revenue | 1.657 |
| EV/EBITDA | 32.70 |
| Quarterly Earnings Growth (YoY) | -43.20% |
| Quarterly Revenue Growth (YoY) | -35.40% |
| Shares Outstanding | $252.88M |
| Float | $110.10M |
| % Insiders | 57.13% |
| % Institutions | 20.11% |
Historical Volatility
HV 10-Day
35.66%
HV 20-Day
30.61%
HV 30-Day
33.57%
HV 60-Day
37.57%
HV Rank
31.0%
Volatility is currently expanding
Analyst Ratings
Consensus ($122.91 target)
1
Strong Buy13
Buy5
HoldMore HEALTHCARE Stocks
Data last updated: 6/11/2026